company background image
DXR logo

Daxor NasdaqCM:DXR Stock Report

Last Price

US$8.57

Market Cap

US$41.2m

7D

2.1%

1Y

-19.0%

Updated

27 Mar, 2024

Data

Company Financials

DXR Stock Overview

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing.

DXR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health2/6
Dividends0/6

Daxor Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Daxor
Historical stock prices
Current Share PriceUS$8.57
52 Week HighUS$13.13
52 Week LowUS$7.11
Beta-0.49
1 Month Change10.32%
3 Month Change-1.95%
1 Year Change-19.04%
3 Year Change-29.18%
5 Year Change-24.29%
Change since IPO59.44%

Recent News & Updates

Recent updates

Daxor reports Q2 results

Aug 25

Daxor partners with Medaxiom to advance awareness of blood volume diagnostic

Jul 21

Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

Mar 08
Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Feb 27
A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Shareholder Returns

DXRUS Medical EquipmentUS Market
7D2.1%2.2%0.4%
1Y-19.0%13.3%28.8%

Return vs Industry: DXR underperformed the US Medical Equipment industry which returned 12% over the past year.

Return vs Market: DXR underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is DXR's price volatile compared to industry and market?
DXR volatility
DXR Average Weekly Movement8.4%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: DXR has not had significant price volatility in the past 3 months.

Volatility Over Time: DXR's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1971n/aMichael Feldschuhhttps://www.daxor.com

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973.

Daxor Corporation Fundamentals Summary

How do Daxor's earnings and revenue compare to its market cap?
DXR fundamental statistics
Market capUS$41.19m
Earnings (TTM)US$280.64k
Revenue (TTM)US$163.42k

146.8x

P/E Ratio

252.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DXR income statement (TTM)
RevenueUS$163.42k
Cost of RevenueUS$0
Gross ProfitUS$163.42k
Other Expenses-US$117.22k
EarningsUS$280.64k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.058
Gross Margin100.00%
Net Profit Margin171.73%
Debt/Equity Ratio2.2%

How did DXR perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.